(Q36684498)

15 August 2017

1 reference

title

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community (English)

1 reference

central nervous system lymphoma

15 August 2017

main subject

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

1

Lauren E Abrey

1 reference

15 August 2017

2

Katherine S Panageas

1 reference

15 August 2017

language of work or name

1 reference

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

47

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

2449-2452

1 reference

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Increasing incidence of primary brain lymphoma in the US

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Primary Central Nervous System Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Combined modality therapy for primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600881272

10.1080/10428190600881272

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference